Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Acacia Research Annual Meeting Available Via Live Webcast and Conference Call.


Business Editors

NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif.--(BUSINESS WIRE)--May 9, 2002

Acacia Research Corporation (Nasdaq:ACRI) announced today that its Annual Meeting of Shareholders will be webcast over the Internet and available through a conference call. The Annual Meeting will be held on Tuesday, May 14, 2002 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

To access the Annual Meeting via the Internet, listeners may go to the company's web site at www.acaciaresearch.com , click on the button marked Company Profile and then click on the link on the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 page. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com.

To access the Annual Meeting via telephone, listeners should dial 800-997-8642 within the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  or 973-694-6836 outside the United States.

After the Annual Meeting, parties may access an archived audio file by dialing 800-428-6051 within the United States or 973-709-2089 outside the United States and entering the code 238058 when prompted. The webcast will also be archived on the company's website.

About Acacia Research Corporation

Acacia Research develops, licenses and provides products for the life science and media technology sectors. Acacia licenses its V-chip technology to television manufacturers and owns pioneering technology for digital streaming and video-on-demand. Acacia's CombiMatrix subsidiary is developing a bio-chip technology for the life science market. Acacia Research's website is located at www.acaciaresearch.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 

Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 9, 2002
Words:403
Previous Article:Vestcom Reports Strong EBITDA and Net Income Growth in First Quarter 2002.
Next Article:SEGA Drafts ESPN to Bring Its Critically Acclaimed SEGA Sports Games to New Levels of Authenticity; Incorporating ESPN Features Into SEGA Sports...



Related Articles
Acacia Research Annual Meeting Available Via Live Webcast.
Acacia Research, Wareforce.com, J.C. Penney and North American Scientific Conference Calls to be Broadcast On Investor Broadcast Network Over the...
Acacia Research Annual Meeting Available Via Live Webcast and Conference Call.
Acacia Research Corporation Announces Second Quarter Financial Results Conference Call; Thursday, July 25, 2001, at 4:30 p.m. Eastern Time -- 1:30...
Acacia Research Corporation Announces Second Quarter Financial Results Conference Call; Wednesday, July 25, 2001, at 4:30 p.m. Eastern Time -- 1:30...
CombiMatrix to Webcast Presentation at the Roth Capital Partners 16th Annual Growth Stock Conference.
CombiMatrix to Webcast Presentation at Invest Northwest 2004 Conference.
CombiMatrix to Webcast Presentation at the Thomas Weisel Partners Healthcare Tailwinds 2004 Conference.
Acacia Technologies to Present at Roth Capital Partners New York Conference.
CombiMatrix to Webcast Presentation at the UBS 2004 Global Life Sciences Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles